These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8339400)

  • 1. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy.
    Hasegawa K; Fujiwara H; Doyama K; Miyamae M; Fujiwara T; Suga S; Mukoyama M; Nakao K; Imura H; Sasayama S
    Circulation; 1993 Aug; 88(2):372-80. PubMed ID: 8339400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
    Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K
    Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tachycardia-induced myocardial ischemia and diastolic dysfunction potentiate secretion of ANP, not BNP, in hypertrophic cardiomyopathy.
    Kido S; Hasebe N; Ishii Y; Kikuchi K
    Am J Physiol Heart Circ Physiol; 2006 Mar; 290(3):H1064-70. PubMed ID: 16172169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis.
    Takemura G; Takatsu Y; Doyama K; Itoh H; Saito Y; Koshiji M; Ando F; Fujiwara T; Nakao K; Fujiwara H
    J Am Coll Cardiol; 1998 Mar; 31(4):754-65. PubMed ID: 9525543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of atrial natriuretic polypeptide in ventricles of heart with hypertrophic cardiomyopathy: an immunohistochemical study of endomyocardial specimens].
    Takemura G; Fujiwara H; Horike K; Kawai C; Mukoyama M; Saito Y; Nakao K; Imura H; Fujiwara T
    J Cardiol; 1991; 21(3):641-7. PubMed ID: 1843515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.
    Yoshimura M; Yasue H; Okumura K; Ogawa H; Jougasaki M; Mukoyama M; Nakao K; Imura H
    Circulation; 1993 Feb; 87(2):464-9. PubMed ID: 8425293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and distribution of atrial natriuretic peptide in human hypertrophic ventricle of hypertensive hearts and hearts with hypertrophic cardiomyopathy.
    Takemura G; Fujiwara H; Mukoyama M; Saito Y; Nakao K; Kawamura A; Ishida M; Kida M; Uegaito T; Tanaka M
    Circulation; 1991 Jan; 83(1):181-90. PubMed ID: 1824622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurohumoral profiles in patients with hypertrophic cardiomyopathy: differences to hypertensive left ventricular hypertrophy.
    Ogino K; Ogura K; Kinugawa T; Osaki S; Kato M; Furuse Y; Kinugasa Y; Tomikura Y; Igawa O; Hisatome I; Shigemasa C
    Circ J; 2004 May; 68(5):444-50. PubMed ID: 15118286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry of atrial and brain natriuretic peptides in control cats and cats with hypertrophic cardiomyopathy.
    Biondo AW; Ehrhart EJ; Sisson DD; Bulmer BJ; De Morais HS; Solter PF
    Vet Pathol; 2003 Sep; 40(5):501-6. PubMed ID: 12949406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venticular expression of atrial and brain natriuretic peptides in patients with myocarditis.
    Takemura G; Fujiwara H; Takatsu Y; Fujiwara T; Nakao K
    Int J Cardiol; 1995 Dec; 52(3):213-22. PubMed ID: 8789180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased plasma levels of adrenomedullin in patients with hypertrophic cardiomyopathy: its relation to endothelin-I, natriuretic peptides and noradrenaline.
    Hamada M; Shigematsu Y; Kawakami H; Minamino N; Kangawa K; Matsuo H; Hiwada K
    Clin Sci (Lond); 1998 Jan; 94(1):21-8. PubMed ID: 9505862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertrophic obstructive and non-obstructive cardiomyopathy in Japan. Diagnosis of the disease with special reference to endomyocardial catheter biopsy.
    Kawai C; Sakurai T; Fujiwara H; Matsumori A; Yui Y
    Eur Heart J; 1983 Nov; 4 Suppl F():121-5. PubMed ID: 6686527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.
    Yamamoto K; Burnett JC; Jougasaki M; Nishimura RA; Bailey KR; Saito Y; Nakao K; Redfield MM
    Hypertension; 1996 Dec; 28(6):988-94. PubMed ID: 8952587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy. An immunohistocytochemical study of the endomyocardial biopsy specimens using specific monoclonal antibodies.
    Hasegawa K; Fujiwara H; Doyama K; Mukoyama M; Nakao K; Fujiwara T; Imura H; Kawai C
    Am J Pathol; 1993 Jan; 142(1):107-16. PubMed ID: 8424448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Left ventricular function at rest and during exercise and the effects of propranolol in patients with hypertrophic cardiomyopathy].
    Amano K; Sakamoto T; Sugimoto T
    J Cardiol Suppl; 1987; 16():35-51. PubMed ID: 3509682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with non-obstructive hypertrophic cardiomyopathy.
    Nakamura T; Sakamoto K; Yamano T; Kikkawa M; Zen K; Hikosaka T; Kubota T; Azuma A; Nishimura T
    J Am Coll Cardiol; 2002 May; 39(10):1657-63. PubMed ID: 12020494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction.
    Matsumoto A; Hirata Y; Momomura S; Suzuki E; Yokoyama I; Sata M; Ohtani Y; Serizawa T
    Am Heart J; 1995 Jan; 129(1):139-45. PubMed ID: 7817907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional assessment by myocardial performance index (Tei index) correlates with plasma brain natriuretic peptide concentration in patients with hypertrophic cardiomyopathy.
    Okawa M; Kitaoka H; Matsumura Y; Kubo T; Yamasaki N; Furuno T; Doi Y
    Circ J; 2005 Aug; 69(8):951-7. PubMed ID: 16041165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased brain natriuretic peptide secretion is a marker of disease progression in nonobstructive hypertrophic cardiomyopathy.
    Pieroni M; Bellocci F; Sanna T; Verardo R; Ierardi C; Maseri A; Frustaci A; Crea F
    J Card Fail; 2007 Jun; 13(5):380-8. PubMed ID: 17602985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of brain natriuretic peptide in various forms of obstruction to the left ventricular outflow tract.
    Fukuda N; Shinohara H; Sakabe K; Nada T; Tamura Y
    J Heart Valve Dis; 2003 May; 12(3):333-40. PubMed ID: 12803333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.